Select Medical authorizes stock repurchase program of up to $1B

Select Medical has authorized a common stock repurchase program to repurchase up to $1.0B worth of shares of its common stock. The common stock repurchase program will remain in effect until December 31, 2025, unless further extended or earlier terminated by the board of directors. Select Medical did not repurchase shares under its authorized stock repurchase program during the year ended December 31, 2023. Since the inception of the common stock repurchase program through December 31, 2023, Select Medical has repurchased 48,234,823 shares at a cost of approximately $600.3M, or $12.45 per share, which includes transaction costs.